UCalgary Scientists Study Optimal THC Dosage for Therapeutic Use

UCalgary scientists study optimal THC dosage for therapeutic use

Watch UCalgary scientists study optimal THC dosage for therapeutic use Video Online, on GlobalNews.ca

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

TORONTO, March 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the initiation of…

Avicanna Sponsors University of Calgary Trial on Oral THC Dosing for Anxiety and Stress

The Marijuana Herald - Marijuana news and information Avicanna says it is sponsoring a new clinical trial at the University of Calgary that will examine how different oral doses of THC affect anxiety, stress and related responses in healthy adults. According to the company, the Phase I study is randomized, double-blinded, placebo-controlled and will be conducted at a single site through the University of Calgary’s Cumming School of Medicine. Th…